Oct 26 (Reuters) - PHARMING GROUP NV:* ‍Q3 NET RESULT IMPROVED TO EUR 7.5 MILLION LOSS COMPARED WITH A LOSS OF EUR 24.5 MILLION IN Q2​* ‍Q3 OPERATING PROFIT UP TO EUR 8.5 MILLION COMPARED WITH A LOSS OF EUR 3.2 MILLION IN Q3 2016​* ‍REVENUES FOR NINE MONTHS TO 30 SEPTEMBER INCREASED TO EUR 56.7 MILLION (2016 EUR 8.7 MILLION)​* ‍EXPECTS FY 2017 REVENUES FROM PRODUCT SALES TO EXCEED ANALYSTS' FORECASTS ​* ‍POSITIVE CASHFLOWS DURING Q3 INCREASED CASH POSITION TO EUR 38.6 MILLION FROM EUR 25.2 MILLION AT JUNE 30 2017​* 9 MONTHS GROSS PROFIT EUR 48.8‍​ MILLION VERSUS EUR 5.5 MILLION YEAR AGO* ‍EXPECTS Q4 RESULTS TO EXCEED Q3 SIGNIFICANTLY​* ‍EXPECTS ACHIEVEMENT OF CONTINUED OPERATING PROFIT AND POSITIVE CASHFLOWS FOR REMAINING QUARTER​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Source: Times of India October 26, 2017 06:45 UTC